STERIS plc (Ireland) Ordinary Shares (STE)
225.81
+3.09 (1.39%)
Steris Corp is a leading provider of infection prevention and sterilization solutions for healthcare and industrial applications
The company offers a broad range of products and services designed to enhance patient safety, improve operational efficiency, and maintain compliance within hospitals and other medical environments. Steris is known for its advanced technologies in sterilization equipment, surgical instruments, and cleaning products, as well as its commitment to infection control protocols. Additionally, Steris supports healthcare facilities with training and advisory services to help optimize their sterilization processes and ensure the highest standards of hygiene.

Healthcare solutions provider Solventum (NYSESOLV)
will be reporting results tomorrow afternoon. Here’s what to look for.
Via StockStory · February 26, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and 2024.
This has weighed on the returns lately as the industry has pulled back by 1.7% over the past six months. This performance is a noticeable divergence from the S&P 500’s 9% return.
Via StockStory · February 17, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns -
over the past six months, healthcare stocks have collectively shed 1.7%. This drop is a stark contrast from the S&P 500’s 9% gain.
Via StockStory · February 17, 2025

Via Benzinga · February 6, 2025

Via Benzinga · November 18, 2024

Via Benzinga · October 24, 2024

Medical equipment and services company Steris (NYSESTE). fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 5.6% year on year to $1.37 billion. Its non-GAAP profit of $2.32 per share was in line with analysts’ consensus estimates.
Via StockStory · February 5, 2025

Via Benzinga · October 24, 2024

Constellation Brands' stock rises despite revising FY25 EPS and sales forecasts and anticipating a significant non-cash goodwill impairment.
Via Benzinga · September 3, 2024

STE stock results show that Steris beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025.
Via InvestorPlace · August 6, 2024

Why the dividend investor may take a look at STERIS PLC (NYSESTE).
Via Chartmill · May 9, 2024

Toast, Teva, Vistra, Equinix, Applovin, IFF, Constellation, Emerson, IP, and STERIS were top performers last week. Are they in your portfolio?
Via Benzinga · May 12, 2024

STE stock results show that Steris beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.
Via InvestorPlace · May 8, 2024
Today's Research Daily features new research reports on 16 major stocks, including Micron Technology, Inc. (MU), Anheuser-Busch InBev SA/NV (BUD), and Duke Energy Corporation (DUK).
Via Talk Markets · May 2, 2024

Companies Reporting Before The Bell • Madison Square Garden (NYSEMSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Via Benzinga · February 7, 2024

At the end of today, December 21, 2023, Steris (NYSESTE) will distribute a dividend payout of $0.52 per share, translating to an annualized dividend yield of 0.99%. Shareholders who held the stock before the ex-dividend date on November 20, 2023 will benefit from this payout.
Via Benzinga · December 21, 2023